Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parsaclisib in Japanese participants with relapsed or refractory follicular lymphoma
NCT04434937Phase 2Completed
- Sponsor
- Incyte
- Start
- Sep 2020
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of parsaclisib in follicular lymphoma (FL), sponsored by Incyte. Started Sep 2020; status: completed.
02
Drugs
parsaclisib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT04434937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04434937.